Effects of basic fibroblast growth factor on rat vocal fold fibroblasts

Annals of Otology, Rhinology and Laryngology

Volumn 119, Issue 10, 2010, Pages 690-696

  Suehiro, Atsushi ^a,b   Hirano, Shigeru ^a   Kishimoto, Yo ^a   Tateya, Ichiro ^a   Rousseau, Bernard ^b   Ito, Juichi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Basic fibroblast growth factor; Extracellular matrix; Gene expression; Rat model; Vocal fold scar

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GROWTH FACTOR; HYALURONIC ACID SYNTHASE 2; PROCOLLAGEN TYPE 1; SCATTER FACTOR; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION; VOCAL CORD; VOCAL CORD DISORDER;

EID: 77958024039     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941011901008     Document Type: Article

References (39)

1. Woo P, Casper J, Colton R, Brewer D. Diagnosis and treatment of persistent dysphonia after laryngeal surgery: a retrospective analysis of 62 patients. Laryngoscope 1994;104:1084-91. (Pubitemid 24284714)
2. Hirano S, Minamiguchi S, Yamashita M, Ohno T, Kanemaru S, Kitamura M. Histologic characterization of human scarred vocal folds. J Voice 2009;23:399-407.
3. Rousseau B, Hirano S, Chan RW, et al. Characterization of chronic vocal fold scarring in a rabbit model. J Voice 2004;18:116-24.
4. Rousseau B, Hirano S, Scheidt TD, et al. Characterization of vocal fold scarring in a canine model. Laryngoscope 2003;113:620-7. (Pubitemid 36406908)
5. Hirano S. Current treatment of vocal fold scarring. Curr Opin Otolaryngol Head Neck Surg 2005;13:143-7.
6. Benninger MS, Alessi D, Archer S, et al. Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg 1996;115:474-82.
7. Branski RC, Rosen CA, Verdolini K, Hebda PA. Acute vocal fold wound healing in a rabbit model. Ann Otol Rhinol Laryngol 2005;114:19-24.
8. Thibeault SL, Gray SD, Bless DM, Chan RW, Ford CN. Histologic and rheologic characterization of vocal fold scarring. J Voice 2002;16:96-104.
9. Rousseau B, Sohn J, Montequin DW, Tateya I, Bless DM. Functional outcomes of reduced hyaluronan in acute vocal fold scar. Ann Otol Rhinol Laryngol 2004;113:767-76.
10. Thibeault SL, Rousseau B, Welham NV, Hirano S, Bless DM. Hyaluronan levels in acute vocal fold scar. Laryngoscope 2004;114:760-4. (Pubitemid 38548793)
11. Hirano S, Bless DM, Rousseau B, Welham N, Scheidt T, Ford CN. Fibronectin and adhesion molecules on canine scarred vocal folds. Laryngoscope 2003;113:966-72.
12. Hong HH, Trackman PC. Cytokine regulation of gingival fibroblast lysyl oxidase, collagen, and elastin. J Periodontol 2002;73:145-52.
13. Hirano S, Bless DM, Heisey D, Ford CN. Effect of growth factors on hyaluronan production by canine vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2003;112:617-24.
14. Heldin P, Laurent TC, Heldin CH. Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J 1989;258:919-22.
15. Ono I, Tateshita T, Inoue M. Effects of a collagen matrix containing basic fibroblast growth factor on wound contraction. J Biomed Mater Res 1999;48:621-30. (Pubitemid 29449586)
16. Akasaka Y, Ono I, Yamashita T, Jimbow K, Ishii T. Basic fibroblast growth factor promotes apoptosis and suppresses granulation tissue formation in acute incisional wounds. J Pathol 2004;203:710-20
17. Suehiro A, Hirano S, Kishimoto Y, Rousseau B, Nakamura T, Ito J. Treatment of acute vocal fold scar with local injection of basic fibroblast growth factor: a canine study. Acta Otolaryngol 2010;130:844-50.
18. Hirano S, Nagai H, Tateya I, Tateya T, Ford CN, Bless DM. Regeneration of aged vocal folds with basic fibroblast growth factor in a rat model: a preliminary report. Ann Otol Rhinol Laryngol 2005;114:304-8.
19. Jong-Hesse YD, Lang GK, Kampmeier J, Lang GE. Effect of growth factors on the differentiation of porcine lens epithelial cells. Klin Monbl Augenheilkd 2004;221:175-9.
20. Shen Y, Li SM, Tang Y, Zhong CC, Liang PH, Chen HH. Effect of basic fibroblast growth factor and hyaluronic acid on proliferation of rabbit chondrocytes in vitro. Chin J Traumatol 2004;7:42-4.
21. Kanemaru S, Nakamura T, Omori K, et al. Regeneration of the vocal fold using autologous mesenchymal stem cells. Ann Otol Rhinol Laryngol 2003;112:915-20. (Pubitemid 37429633)
22. Kanemaru S, Nakamura T, Yamashita M, et al. Destiny of autologous bone marrow-derived stromal cells implanted in the vocal fold. Ann Otol Rhinol Laryngol 2005;114:907-12.
23. Hirano S, Bless DM, Nagai H, et al. Growth factor therapy for vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol 2004;113:777-85.
24. Ohno T, Hirano S, Kanemaru S, et al. Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol 2007;116:762-9.
25. Ohno T, French LC, Hirano S, Ossoff RH, Rousseau B. Effect of hepatocyte growth factor on gene expression of extracellular matrix during wound healing of the injured rat vocal fold. Ann Otol Rhinol Laryngol 2008;117:696-702.
26. Tabata Y. Tissue regeneration based on growth factor release. Tissue Eng 2003;9(suppl 1):S5-S15.
27. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008;16:585-601.
28. Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000;7:165-97.
29. Sogabe Y, Abe M, Yokoyama Y, Ishikawa O. Basic fibroblast growth factor stimulates human keratinocyte motility by Rac activation. Wound Repair Regen 2006;14:457-62. (Pubitemid 44266603)
30. Grellner W, Georg T, Wilske J. Quantitative analysis of proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha) in human skin wounds. Forensic Sci Int 2000;113:251-64.
31. Sasaki T. The effects of basic fibroblast growth factor and doxorubicin on cultured human skin fibroblasts: relevance to wound healing. J Dermatol 1992;19:664-6.
32. Richard JL, Parer-Richard C, Daures JP, et al. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care 1995;18:64-9.
33. Robson MC, Phillips LG, Lawrence WT, et al. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 1992;216:401-8.
34. Margolis DJ, Lewis VL. A literature assessment of the use of miscellaneous topical agents, growth factors, and skin equivalents for the treatment of pressure ulcers. Dermatol Surg 1995;21:145-8.
35. Akita S, Akino K, Imaizumi T, et al. The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor. J Burn Care Res 2006;27:333-8.
36. Ogawa K, Asonuma K, Inomata Y, et al. The efficacy of prevascularization by basic FGF for hepatocyte transplantation using polymer devices in rats. Cell Transplant 2001;10:723-9. (Pubitemid 34075832)
37. Muneuchi G, Suzuki S, Moriue T, Igawa HH. Combined treatment using artificial dermis and basic fibroblast growth factor (bFGF) for intractable fingertip ulcers caused by atypical burn injuries. Burns 2005;31:514-7.
38. Robson MC. The role of growth factors in the healing of chronic wounds. Wound Repair Regen 1997;5:12-7.
39. Onimaru M, Yonemitsu Y, Tanii M, et al. Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs. Circ Res 2002;91:923-30.